Mechanism of transcriptional repression by TEL/RUNX1 fusion protein
- PMID: 15179033
Mechanism of transcriptional repression by TEL/RUNX1 fusion protein
Abstract
Human chromosomal translocation t(12;21)(p12;q22) is one of the most frequent rearrangement in human leukemia, and produces the TEL/RUNX1 fusion protein. The TEL/RUNX1 fusion protein creates a transcriptional repressor that interferes in dominant fashion with RUNX1-dependent transactivation. Here, we demonstrate that the repressor activity of TEL/ RUNX1 differs from that of TEL, even though both TEL and TEL/RUNX1 interact with the nuclear hormone co-repressor (N-CoR) and histone deacetylase (mSin3A) in vivo. Co-immunoprecipitation experiments demonstrated that TEL/RUNX1 forms homodimers in vivo, and heterodimerizes with the TEL when the two proteins are expressed together. These interactions require the HLH (helix-loop-helix) region of TEL. Immunoprecipitation and immunofluorescence analysis showed that p300 interacts with TEL/RUNX1 and is sequestered in the cytoplasm by it. These results suggest that the p300-TEL/RUNX1 complex and heterodimerization of TEL/RUNX1 with TEL may be responsible for the ability of TEL/RUNX1 to inhibit RUNX1-mediated transactivation. It appears that loss of TEL function activates a pathway that cooperates with TEL/RUNX1 and sequesters coactivator(s) into nonfunctional complex in the cytoplasm thus inhibiting transcription of target genes.
Similar articles
-
Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins.Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S31-4. doi: 10.1007/s002800100302. Cancer Chemother Pharmacol. 2001. PMID: 11587363 Review.
-
Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.Mol Cell Biol. 1999 Oct;19(10):6566-74. doi: 10.1128/MCB.19.10.6566. Mol Cell Biol. 1999. PMID: 10490596 Free PMC article.
-
Correlation between cellular localization of TEL/AML1 fusion protein and repression of AML1-mediated transactivation of CR1 gene.Biochem Biophys Res Commun. 2002 Sep 13;297(1):91-5. doi: 10.1016/s0006-291x(02)02075-2. Biochem Biophys Res Commun. 2002. PMID: 12220513
-
ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jkappa/SHARP-mediated repression of notch target genes.Mol Cell Biol. 2008 May;28(10):3502-12. doi: 10.1128/MCB.01966-07. Epub 2008 Mar 10. Mol Cell Biol. 2008. PMID: 18332109 Free PMC article.
-
Molecular targeting of aberrant transcription factors in leukemia: strategies for RUNX1/ETO.Curr Drug Targets. 2010 Sep;11(9):1181-91. doi: 10.2174/138945010792006744. Curr Drug Targets. 2010. PMID: 20583973 Review.
Cited by
-
Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally.Cancer Res. 2008 Dec 1;68(23):9935-44. doi: 10.1158/0008-5472.CAN-08-2139. Cancer Res. 2008. PMID: 19047175 Free PMC article.
-
Identification of new ETV6 modulators through a high-throughput functional screening.iScience. 2022 Feb 2;25(3):103858. doi: 10.1016/j.isci.2022.103858. eCollection 2022 Mar 18. iScience. 2022. PMID: 35198911 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous